Das Herbstsemester 2020 findet in einer gemischten Form aus Online- und Präsenzunterricht statt.
Bitte lesen Sie die publizierten Informationen zu den einzelnen Lehrveranstaltungen genau.

511-0000-00L  Drug Discovery and Development

SemesterHerbstsemester 2017
DozierendeU. Thibaut, J. Hall
Periodizitätjährlich wiederkehrende Veranstaltung
LehrspracheEnglisch


KurzbeschreibungThis course provides an overview over the concepts and processes employed in today's drug discovery and development. It has an introductory character but will also provide more detailed insights employing real life examples. The course combines lectures and interactive elements with active participation of the students.
LernzielStudents
- Understand the drug discovery process and can explain major approaches and relevant technical terms (for details see lecture notes).
- Understand and appreciate the content and timing of drug development process steps, development phases and decision criteria.
- Understand the concepts underlying drug product development through all the phases from preclinical and clinical development to regulatory submission, approval and market launch.
- Can differentiate between small molecule drug development and biological drug development.
- Understand the most important differences between legal and regulatory requirements for drug development and approval for the major markets EU and USA.
InhaltDrug Discovery (day 1):

Introduction to drug discovery: the concepts of drug target selection, ligands/leads, the developability of drug candidates;
Overview over the principal approaches to drug discovery: rational drug design, the natural product approach, serendipity, repurposing as well as chemical libraries and high-throughput screening.

Drug Development (days 2 and 3):

Introduction to the industrial drug product development processes covering the following phases: preclinical research and development, clinical development, regulatory processes and market launch.
R&D support processes such as project management, quality management, pharmacovigilance and pharmacoeconomics will be covered as well as organizational and governance aspects of the pharmaceutical industry.
SkriptWill be published on "mystudies"
LiteraturG. Nahler (Hrsg.) Dictionary of pharmaceutical medicine, Springer, Wien, 2013 (3rd edition)
Further readings will be listed in the lecture notes.
Voraussetzungen / BesonderesThis course provides the essential basic knowledge required for the industry-specific modules of the spring semester.